HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock.

Abstract
Sepsis remains a serious clinical problem despite intense efforts to improve survival. In this study, the efficacy of ertapenem combined with the cathelicidin tritrpticin was investigated in two rat models of septic shock. Main outcome measures were bacterial growth in blood, peritoneum, spleen, liver, and mesenteric lymph nodes; endotoxin, interleukin 6, and tumor necrosis factor alpha concentrations in plasma; and lethality. Adult male Wistar rats were given (1) an intraperitoneal injection of 1 mg Escherichia coli serotype 0111:B4 LPS or (2) intra-abdominal sepsis induced via cecal ligation and puncture. For each model, all animals were randomized to receive intraperitoneally isotonic sodium chloride solution, 1 mg/kg tritrpticin, 15 mg/kg ertapenem, and 1 mg/kg tritrpticin combined with 15 mg/kg ertapenem. Each group included 20 animals. All compounds significantly reduced bacterial growth and lethality as compared with saline treatment. Treatment with tritrpticin resulted in significant decrease in plasma endotoxin and cytokine levels, whereas ertapenem exerted opposite effect. The combination between tritrpticin and ertapenem proved to be the most effective treatment in reducing all variables measured. In conclusion, tritrpticin enhances ertapenem efficacy in gram-negative septic shock rat models.
AuthorsRoberto Ghiselli, Oscar Cirioni, Andrea Giacometti, Federico Mocchegiani, Fiorenza Orlando, Carmela Silvestri, Alberto Licci, Agnese Della Vittoria, Giorgio Scalise, Vittorio Saba
JournalShock (Augusta, Ga.) (Shock) Vol. 26 Issue 2 Pg. 195-200 (Aug 2006) ISSN: 1073-2322 [Print] United States
PMID16878029 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Endotoxins
  • Interleukin-6
  • Oligopeptides
  • Tumor Necrosis Factor-alpha
  • beta-Lactams
  • tritrpticin
  • Ertapenem
  • Cathelicidins
Topics
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • Antimicrobial Cationic Peptides (chemistry)
  • Cecum (surgery)
  • Disease Models, Animal
  • Drug Synergism
  • Endotoxins (blood)
  • Enterococcus faecalis (drug effects)
  • Ertapenem
  • Escherichia coli (drug effects)
  • Escherichia coli Infections (drug therapy)
  • Interleukin-6 (blood)
  • Ligation
  • Male
  • Microbial Sensitivity Tests
  • Oligopeptides (chemistry, pharmacology)
  • Rats
  • Rats, Wistar
  • Shock, Septic (drug therapy, microbiology, mortality)
  • Tumor Necrosis Factor-alpha (metabolism)
  • beta-Lactams (pharmacology)
  • Cathelicidins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: